Cargando…
Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
Cutaneous leishmaniasis (CL) is common in Ethiopia, but the national guideline does not offer specific treatment recommendations. Consequently, different treatment regimens are used in the country, without quality evidence. In Boru Meda Hospital, sodium stibogluconate (SSG) is routinely used in comb...
Autores principales: | van Henten, Saskia, Bialfew, Fentaw, Hassen, Seid, Tilahun, Feleke, van Griensven, Johan, Abdela, Seid Getahun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459856/ https://www.ncbi.nlm.nih.gov/pubmed/37624352 http://dx.doi.org/10.3390/tropicalmed8080414 |
Ejemplares similares
-
Activity limitation and social participation restriction among leprosy patients in Boru Meda Hospital, Amhara Region, Ethiopia
por: Abdela, Seid Getahun, et al.
Publicado: (2020) -
Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial
por: Tilahun Zewdu, Feleke, et al.
Publicado: (2022) -
Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
por: van Henten, Saskia, et al.
Publicado: (2021) -
Clinical Profile and Treatment of COVID-19 Patients: Experiences from an Ethiopian Treatment Center
por: Abdela, Seid Getahun, et al.
Publicado: (2021) -
Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?
por: Abdela, Seid Getahun, et al.
Publicado: (2021)